Highest-materiality recent filing
Cell Source completes $4.76M offering of 8% convertible notes with warrants
Completed private offering of $4,760,170 aggregate principal of 8% convertible notes.
Cell Source issues $2.5M convertible note to new board member George Verstraete at 10% interest
Appointed George Verstraete to the board; he agreed to loan $2.5M via a convertible promissory note.
On July 18, 2022, each of Ben Friedman and David Zolty resigned his position as a director of Cell Source, Inc. (the “Company”).
On July 18, 2022, each of Ben Friedman and David Zolty resigned his position as a director of Cell Source, Inc. (the “Company”).
On May 6, 2022 Itamar Shimrat resigned his position as a director of Cell Source, Inc.
On March 10, 2022, the Board of Directors of the Company appointed George Verstraete as a member of the Board.
Max materiality 0.70 · Median 0.50 · Most common event debt